• Explore /
  • Poster
  • / Phase II study of nivolumab (ONO-4538/BMS-936558) in patients with esophageal cancer: Preliminary report of overall survival.

Phase II study of nivolumab (ONO-4538/BMS-936558) in patients with esophageal cancer: Preliminary report of overall survival.

Abstract Poster

Authors

null

Takashi Kojima

Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan

Takashi Kojima , Hiroki Hara , Kensei Yamaguchi , Shuichi Hironaka , Satoru Iwasa , Ken Kato , Takahiro Tsushima , Hirofumi Yasui , Takashi Ura , Kei Muro , Taroh Satoh , Yuichiro Doki , Atsushi Ohtsu , Yasuo Hamamoto , Yuko Kitagawa

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session A: Cancers of the Esophagus and Stomach

Track

Cancers of the Esophagus and Stomach

Sub Track

Translational Research

Clinical Trial Registration Number

142422

Citation

J Clin Oncol 34, 2016 (suppl 4S; abstr TPS175)

DOI

10.1200/jco.2016.34.4_suppl.tps175

Abstract #

TPS175

Poster Bd #

O1

Abstract Disclosures

Similar Posters

First Author: Deirdre Jill Cohen

First Author: David A. Reardon

First Author: Kohei Shitara

Poster

2023 ASCO Annual Meeting

Phase II trial of XmAb20717 (vudalimab) in patients with advanced biliary tract cancers.

Phase II trial of XmAb20717 (vudalimab) in patients with advanced biliary tract cancers.

First Author: William Joseph Chapin